drugset
drugset / Trial / NCT01829893

PK Comparison of GL2701 With Finasteride and Tamsulosin in Combination

NCT01829893 ↗

Phase 1 Completed 26 enrolled Korea University Anam Hospital GL Pharm Tech Corporation · collab
RandomizedCrossoverOpen-label

Summary

To compare the relative bioavailability and pharmacokinetic characteristics of a newly single pill combination of finasteride and tamsulosin with a conventional combination of finasteride and tamsulosin in healthy subjects with a single dose, randomized, open-label, 2-sequence -2period crossover study.

Timeline

Start
2012-01
Primary completion
2012-02
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Finasteride Small molecule 5 mg Oral
Comparator Tamsulosin Other / unclassified 0.2 mg Oral

Indications

benign prostatic hyperplasia